ICH guideline E11A on pediatric extrapolation - Scientific guideline
Table of contents
This guideline provides recommendations for harmonised approaches for paediatric extrapolation to support the development and authorisation of paediatric medicines. It provides a framework for using extrapolation as a tool to support paediatric drug development that encompasses an iterative process for understanding the existing information available, the gaps in information needed to inform development and ways to generate additional information when needed.
Please note that a case example has been generated to help contextualise the main document and further inform the public consultation process.
Keywords: Paediatric medicinal product development, children, adolescents, extrapolation, pharmacokinetic, modelling and simulation, statistics
-
List item
Draft ICH guideline E11A on pediatric extrapolation Step 2b (PDF/745.43 KB)
Draft: consultation closed
First published: 06/04/2022
Consultation dates: 06/04/2022 to 06/08/2022
EMA/CHMP/ICH/205218/2022 -
List item
Overview of comments received on ICH guideline E11A on pediatric extrapolation Step 2bEMA/CHMP/ICH/205218/2022 (PDF/543.32 KB)
First published: 26/09/2022
Last updated: 01/12/2022
EMA/CHMP/ICH/205218/2022 Corr.